Tuesday, August 22, 2017 10:19:04 PM
Amending Agreement
Pursuant to the terms of the Amending Agreement, the Company will, upon closing of the Transaction, issue to MJ BioPharma shareholders an aggregate of 4,000,000 common shares in the capital of the Company (the "Payment Shares") at a deemed price of CDN$0.20 per Payment Share. Previously, the Company was to issue 9,750,000 Payment Shares. The Payment Shares will be subject to escrow conditions and/or resale restrictions as required by applicable securities laws and the policies of the Canadian Securities Exchange (the "CSE"). In addition, the termination date has been extended to September 30, 2017.
http://www.marketwired.com/press-release/vinergy-resources-announces-amending-agreement-definitive-agreement-with-mj-biopharma-cse-vin-2230911.htm
Looks like they are getting MJ Biopharma for cheaper than before??
Recent MBAIF News
- Emerging Markets Report: Meeting the Moment • InvestorsHub NewsWire • 11/21/2023 04:18:47 PM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Mawson Finland Provides Update on Exploration Activities at Rajapalot • MFL • Aug 21, 2024 9:06 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM